Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome
{{output}}
Background: Many patients require revascularization after index acute coronary syndrome (ACS). Lipoprotein(a) is thought to play a pathogenic role in atherothrombosis. In ODYSSEY OUTCOMES, alirocumab reduced major adverse cardiov... ...
